A 32-year-old multigravida at 36 weeks gestation presents to the labor and delivery unit with complaints of severe headache and blurred vision. Her blood pressure is 180/115 mmHg, and she has 4+ proteinuria. The physician has ordered magnesium sulfate therapy. What is the priority nursing intervention before initiating magnesium sulfate?

Ensuring calcium gluconate is available at the bedside is the priority before initiating magnesium sulfate, as it is the antidote for magnesium toxicity. Other interventions like checking reflexes or obtaining baseline levels are important but secondary to immediate safety.

Understanding the Clinical Scenario

This question presents a classic case of severe preeclampsia. The client exhibits hallmark signs: severe-range hypertension (170/110 mmHg), significant proteinuria (3+), and symptoms of central nervous system irritability (severe headache, visual disturbances) and hepatic involvement (epigastric pain, elevated liver enzymes). These findings indicate a high risk for progression to eclampsia, a life-threatening condition characterized by generalized seizures ^[4]. The physician's order for magnesium sulfate infusion is a critical prophylactic measure, as magnesium sulfate is the drug of choice for seizure prevention in this context [1, 2].

Analyzing the Priority Nursing Intervention

The question asks for the priority nursing intervention before initiating the magnesium sulfate infusion. While all options are important components of care for a patient on magnesium sulfate, the priority is dictated by patient safety and the immediate risk of a life-threatening adverse effect.

- Option 1: Assess the client's deep tendon reflexes. This is a crucial ongoing assessment to monitor for magnesium toxicity during the infusion, not the single most critical preparatory step. The therapeutic window for magnesium sulfate is narrow, and loss of deep tendon reflexes (DTRs) is often the first sign of toxicity ^[2]. However, this assessment is done to establish a baseline and then serially, not as an absolute safety net before starting the drug.

- Option 2: Ensure that calcium gluconate is readily available at the bedside. This is the priority intervention. Magnesium sulfate can rapidly lead to toxicity, manifesting as respiratory depression, loss of DTRs, and cardiac arrest. Calcium gluconate is the direct pharmacological antagonist that can reverse these life-threatening effects ^[2]. Having it immediately available at the bedside is a non-negotiable safety standard, akin to having naloxone ready before administering IV opioids. If toxicity occurs, there is no time to retrieve the antidote from a supply room.

- Option 3: Place an indwelling urinary catheter to monitor output. This is an important intervention for monitoring renal function and fluid balance, especially since magnesium is excreted renally. Decreased urine output is a key sign of worsening preeclampsia and increases the risk of magnesium toxicity ^[2]. However, catheter placement is an invasive procedure and is not the immediate, life-saving safety check required before starting the infusion.

- Option 4: Draw a baseline serum magnesium level. While a baseline level can be helpful, it is not the standard of care or a required safety measure before initiating standard seizure prophylaxis dosing. The clinical assessment of therapeutic effect and toxicity is primarily based on physical examination findings (DTRs, respiratory rate, level of consciousness), not serial serum levels ^[2]. This action does not directly address the immediate risk of a sudden, adverse reaction to the first dose.

Pathophysiology and Clinical Rationale

The rationale for the priority is rooted in the pharmacology of magnesium sulfate and the pathophysiology of preeclampsia. Magnesium sulfate acts as a central nervous system depressant and a calcium antagonist, which is why it is effective for seizure prophylaxis ^[2]. However, this same mechanism makes it a high-risk medication. The therapeutic window is narrow, and the transition from a therapeutic to a toxic level can be abrupt.

The primary danger is magnesium toxicity, which causes neuromuscular blockade and smooth muscle relaxation. Clinically, this progresses in a predictable sequence:
1. Loss of deep tendon reflexes (patellar reflex is most commonly assessed).
2. Respiratory depression (a respiratory rate below 12 breaths/min is a critical warning).
3. Cardiac conduction abnormalities and eventual cardiac arrest ^[2].

Calcium gluconate works by directly antagonizing the effects of magnesium at the neuromuscular junction and in cardiac muscle. Administering calcium gluconate intravenously can rapidly reverse the cardiorespiratory depression caused by magnesium toxicity. Therefore, verifying its immediate availability is the most time-sensitive safety intervention that must be completed before the infusion is connected to the patient. All other assessments are secondary to having the life-saving antidote ready at the point of care ^[2].